Cell-mediated lympholysis studies in renal allograft recipients

Transplantation
E GoulmyJ J van Rood

Abstract

Cell-mediated lympholysis (CML) reactivity against the splenocytes of the kidney donor might be a good in vitro correlate of the homograft reaction. The present study was performed in an attempt to determine whether CML nonreactivity between unrelated donor-recipient combinations occur and, if so, under what conditions. We were able to show that CML nonreactivity occurs between unrelated donor-recipient combinations in 70% of the nonrejecting patients, whereas all of the rejecting patients were CML reactive. Patients with CML nonreactivity did clinically well more frequently than those that were CML reactive. The question as to whether or not such variables as HLA-A, B, and DR match and sex, the number of pretransplant blood transfusions, and the degree of presensitization, etc. predispose to the development of donor-specific CML nonreactivity was studied as well. Sex and compatibility for HLA-B antigens between donor and recipient might be such factors.

Citations

Apr 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S QianT E Starzl
Jan 1, 1994·Journal of Clinical Laboratory Analysis·J SteinmannW Müller-Ruchholtz
Jan 1, 1995·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·N L ReinsmoenA J Matas
Nov 1, 1985·Human Immunology·D J CohenT Mohanakumar
Sep 26, 2001·Infectious Disease Clinics of North America·R Patel
May 15, 1997·Transplantation·J H FechnerS J Knechtle
Aug 10, 2000·Transplant International : Official Journal of the European Society for Organ Transplantation·G A BöhmigG J Zlabinger
Jan 1, 2003·Transplant Immunology·Ahmed S ShokerRezvan Choudry
Feb 1, 1995·European Journal of Immunology·V Thomas-VaslinA Bandeira
Dec 2, 2006·Transplant Immunology·Mats EngstrandCecilia Johnsson
Jan 30, 2015·Science Translational Medicine·Heather MorrisMegan Sykes
Jan 14, 2016·Transplantation·Susan DeWolfMegan Sykes
Apr 28, 2017·Clinical and Experimental Immunology·A MassartD Abramowicz
Oct 1, 1994·The Journal of Urology·W C WaltzerF T Rapaport
Feb 4, 2010·Molecular Diagnosis & Therapy·Georg A BöhmigMarcus D Säemann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.